Senate Democrats are urging one of the manufacturers of the abortion pill mifepristone to update the drug’s labeling to make it easier for patients to access the medication to reduce complications from a miscarriage in states with restrictive abortion laws.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.